跳至主要内容
临床试验/NCT06978595
NCT06978595已完成不适用

Primary Colorectal Signet Ring Cell Carcinoma and the Risk of Multiple Primary Gastrointestinal Malignancies: a Retrospective Cohort Based on SEER Database From 2000-2021

asmaa salama ibrahim1 个研究点 分布在 1 个国家目标入组 8,171 人开始时间: 2000年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
8,171
试验地点
1
主要终点
The standardized incidence ratio of developing gastrointestinal second primary malignancies following primary colorectal signet ring cell carcinoma

研究概览

简要总结

This original research investigates the critical issue of gastrointestinal (GI) second primary malignancies (SPMs) in patients with signet ring cell carcinoma (SRCC), a rare and aggressive subtype of colorectal cancer. Utilizing the Surveillance, Epidemiology, and End Results (SEER) database, the investigators assessed the risk of GI SPMs, particularly within 2-11 months post-SRCC diagnosis.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with primary colorectal SRCC between 2000 and 2021
  • Latency exclusion period of two months

排除标准

  • patients with unknown age data

结局指标

主要结局

The standardized incidence ratio of developing gastrointestinal second primary malignancies following primary colorectal signet ring cell carcinoma

时间窗: from Jan, 2000 till Dec, 2021

The surveillance, epidemiology and End Results (SEER) database was used to calculate the standardized incidence ratio (SIR) as Observed/Expected (O/E) for second primary gastrointestinal malignancies. Patients diagnosed with primary colorectal SRCC between 2000 and 2021 were included. The event was defined as the appearance of an SPM in a different site from the original cancer at a new GI organ (esophagus, stomach, small intestine, cecum, appendix, rectum, anus and anal canal, liver, gallbladder, intrahepatic bile duct, pancreas, retro-peritoneum, and colon).

次要结局

  • The excess risk of developing gastrointestinal second primary malignancies following primary colorectal signet ring cell carcinoma(from Jan, 2000 till Dec, 2021)

研究者

发起方
asmaa salama ibrahim
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

asmaa salama ibrahim

Resident physician of gastroenterology

Suez Canal University

研究点 (1)

Loading locations...

相似试验

Primary Colorectal Signet Ring Cell Carcinoma and... | 临床试验